The estimated Net Worth of Eric Schaefer is at least $299 millier dollars as of 22 February 2021. Mr. Schaefer owns over 3,842 units of Pacific Biosciences of California Inc stock worth over $148,636 and over the last 4 years he sold PACB stock worth over $150,606. In addition, he makes $0 as Chief Accounting Officer et Vice President at Pacific Biosciences of California Inc.
Eric has made over 1 trades of the Pacific Biosciences of California Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 3,842 units of PACB stock worth $150,606 on 22 February 2021.
The largest trade he's ever made was selling 3,842 units of Pacific Biosciences of California Inc stock on 22 February 2021 worth over $150,606. On average, Eric trades about 1,921 units every 0 days since 2021. As of 22 February 2021 he still owns at least 88,474 units of Pacific Biosciences of California Inc stock.
You can see the complete history of Mr. Schaefer stock trades at the bottom of the page.
Eric E. Schaefer serves as Chief Accounting Officer, Vice President of the Company. He was previously the Company’s Senior Director, Corporate Controller since March 2019 and previously served as the Company’s Assistant Controller since June 2012. Prior to joining the Company, Mr. Schaefer served as an auditor at PricewaterhouseCoopers from 2005 to 2012, most recently as Audit Manager. Mr. Schaefer holds a B.S. in Accounting from Brigham Young University and is a certified public accountant.
Eric Schaefer is 40, he's been the Chief Accounting Officer et Vice President of Pacific Biosciences of California Inc since 2020. There are 18 older and no younger executives at Pacific Biosciences of California Inc. The oldest executive at Pacific Biosciences of California Inc is Lucy Shapiro, 79, who is the Independent Director.
Eric's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan et Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include: